https://www.benzinga.com/views/taxonomy/term/64 en https://www.benzinga.com/pressreleases/26/04/g52081092/seven-goranson-bain-ausley-attorneys-named-to-d-magazines-2026-best-lawyers-in-dallas?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">Dallas, Texas, April 27, 2026 (GLOBE NEWSWIRE) -- Seven attorneys at Goranson Bain Ausley – one of the largest family law firms in Texas – have been named to D Magazine&#39;s 2026 &#39;Best Lawyers in Dallas&#39; list, the most honorees from any single family law firm. The recognition is determined through peer nomination and independent evaluation within the legal community.</p> <p align="justify">The attorneys recognized are <strong>Kevin Davidson, Esther Donald, Aimee Pingenot Key, Kathryn Murphy, Jeff Domen, Lindsey Obenhaus, and Angel Berbarie</strong>.</p> <p align="justify"><em>"Having seven ...</em></p><p><a href=https://www.benzinga.com/pressreleases/26/04/g52081092/seven-goranson-bain-ausley-attorneys-named-to-d-magazines-2026-best-lawyers-in-dallas?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Seven Goranson Bain Ausley Attorneys Named to D Magazine&#039;s 2026 Best Lawyers in Dallas>Full story available on Benzinga.com</a></p> Advisory M&A News Legal Press Releases Mon, 27 Apr 2026 21:00:00 +0000 Globe Newswire 52081092 at https://www.benzinga.com https://www.benzinga.com/news/movers-shakers/26/04/52079716/musks-openai-trial-puts-sam-altman-and-greg-brockman-under-spotlight?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p>The courtroom fight between&nbsp;<strong>Elon Musk</strong>&nbsp;and&nbsp;OpenAI&nbsp;moved closer to a jury trial in Oakland on Monday, with the dispute threatening to reshape who runs the AI company and how it is ultimately organized. In parallel filings, Musk has pressed for leadership changes — including efforts to&nbsp;strip&nbsp;OpenAI<strong> </strong><a href="https://www.benzinga.com/news/legal/26/04/51695765/elon-musk-seeks-ouster-sam-altman-greg-brockman-openai-harassment-claim" target="_blank" rel="noreferrer noopener"><strong>CEO Sam Altman</strong></a>&nbsp;and&nbsp;<strong>Greg Brockman</strong>&nbsp;of their roles — while OpenAI has framed the case as a competitive attack tied to Musk&#039;s push to build&nbsp;xAI.</p> <p>Reuters reported the trial record includes internal papers and personal writings used to argue over whether OpenAI drifted from its original nonprofit purpose into a profit-first enterprise. Jury selection is set for Monday, with opening statements expected on Tuesday.</p> <p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-9-16 wp-has-aspect-ratio"><br /> <div class="wp-block-embed__wrapper"> <iframe loading="lazy" title="Elon Musk vs Sam Altman In OpenAI Trial" width="422" height="750" src="https://www.youtube.com/embed/0Pmo4SmfiMg?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe> </div> <p><figcaption class="wp-element-caption">Check out ...</figcaption></p></figure></p><p><a href=https://www.benzinga.com/news/movers-shakers/26/04/52079716/musks-openai-trial-puts-sam-altman-and-greg-brockman-under-spotlight?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Musk&#039;s OpenAI Trial Puts Sam Altman And Greg Brockman Under Spotlight>Full story available on Benzinga.com</a></p> gtrends M&A META MSFT News Private Markets Tech MSFT US5949181045 META News M&A Private Markets Tech Benzinga Mon, 27 Apr 2026 20:24:37 +0000 Leif Abel 52079716 at https://www.benzinga.com https://www.benzinga.com/markets/private-markets/26/04/52075829/thrive-capital-stake-san-francisco-giants?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>Thrive Capital </strong>has bought a small stake in the <strong>San Francisco Giants </strong>through a <a href="https://www.benzinga.com/topic/venture-capital">new holding company</a> called Thrive Eternal.</p> <p>Thrive Eternal is a permanent holding company that will focus on assets with &#8220;qualities that cannot be replicated by technology,&#8221; founder Josh Kushner wrote in a<a href="https://x.com/JoshuaKushner/status/2047690904753058293?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet"> post </a>on X.&nbsp;</p> <p>"Thrive Eternal is built on the belief that the most enduring of these assets share common characteristics: they benefit from long-term stewardship, they compound through cultural resonance, and they are enhanced by technology rather than displaced by it," Kushner wrote.</p> <p>The vehicle is funded by existing investors in Thrive&#039;s venture capital and growth equity funds.&nbsp;</p> <p>Details on the transaction were not disclosed, although Axios <a href="https://www.axios.com/2026/04/27/joshua-kushner-sports-giants-thrive-eternal">reported</a> that it is for a sub-10% stake and includes both primary and secondary purchases.&nbsp;</p> <p><strong>Sixth Street Partners</strong> and <strong>Arctos, </strong>two of the club&#039;s existing institutional owners, have kept their stake in the franchise.The deal remains subject to MLB approval.</p> <h3 class="wp-block-heading">Big Names Join The Strategy</h3> <p>Last week, it was ...</p><p><a href=https://www.benzinga.com/markets/private-markets/26/04/52075829/thrive-capital-stake-san-francisco-giants?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Thrive Capital Takes On Pro Sports With A Stake In The San Francisco Giants>Full story available on Benzinga.com</a></p> APO BX DIS KKR M&A Private Markets Stories That Matter Venture Capital Markets APO US0376123065 BX US09253U1088 DIS US2546871060 KKR US48248M1027 M&A Private Markets Markets Benzinga Mon, 27 Apr 2026 18:50:38 +0000 Caroline Ryan 52075829 at https://www.benzinga.com https://www.benzinga.com/pressreleases/26/04/g52073734/nexans-to-acquire-republic-wire-establishing-a-strategic-platform-in-the-united-states?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p><b>Nexans to acquire Republic Wire, establishing a strategic platform in the United States </b></p> <ul type="disc"> <li><b>Nexans significantly expands its presence in the attractive and strategic low voltage business in the U.S. through the acquisition of Republic Wire, a high-quality asset with a well-established nationwide sales network </b></li> <li><b>Transaction complements Nexans&#39; existing North American footprint, creating a compelling growth platform in the U.S. </b></li> </ul> <p><b>Paris, April 27</b>^<b>t</b>^<b>h</b><b>, 2026</b> – Nexans today announced that it has signed an agreement for the acquisition of 100% of the share capital of Republic Wire, Inc. (&#34;Republic Wire&#34;), an established American manufacturer of low-voltage copper and aluminum wire products headquartered in Cincinnati, Ohio. </p> <p align="justify">Founded in 1982 and family-owned, Republic Wire is a recognized manufacturer of low-voltage wiring products serving electrical wholesale distributors, utilities and municipalities across the United States and Canada. Over the 12 month period through February 2026, Republic Wire generated c.€520¹^,² million in current revenue. The company operates a fully invested industrial platform comprising a 32.5k square meters manufacturing facility equipped with significant automation, and a newly completed 30k square meters warehouse and distribution center. Republic Wire employs over 200 highly skilled associates and recently completed a significant expansion program that will be fully online by the end of 2026, increasing its production capacity by approximately 30%.</p> <p align="justify"><b>Strategic Rationale</b></p> <p align="justify">The acquisition of Republic Wire is an important step in Nexans&#39; strategy to expand its geographic footprint to the United States, one of the world&#39;s largest markets and among the fastest-growing for low- and medium-voltage cables. The U.S. low-voltage segment, estimated at c.€12 billion³, is mainly driven by sustained demand across residential, commercial and data center expansion.</p> <p align="justify">The acquisition of Republic Wire is perfectly consistent with Nexans&#39; strategy and will allow Nexans to:</p> <ul type="disc"> <li style="text-align:justify;">Establish an expanded manufacturing and distribution platform in the high-growth U.S. geography, complementing the recent acquisition of Electro Cables in Canada;</li> <li style="text-align:justify;">Access residential and commercial channels through Republic Wire&#39;s strong sales agent and distributor network, building on Nexans&#039; proven global distributor relationships and benefitting from Nexans&#39; broader complementary product portfolio into additional high-growth verticals, including data centers;</li> <li style="text-align:justify;">Create a platform for future organic and inorganic growth across the U.S., ensuring that the Group will benefit through the cycle from structural growth in the region; and</li> <li style="text-align:justify;">Generate c.€23¹ million in run-rate synergies within 3 years, driven by commercial cross-selling opportunities rolling out Nexans&#39; comprehensive product offering in medium-voltage and grid solutions, technology synergies through the deployment of Nexans&#39; proprietary manufacturing IP, and industrial synergies through purchasing scale, manufacturing mutualization and efficiency.</li> </ul> <p align="justify"><b>Financial Highlights </b></p> <p align="justify">The transaction represents a total enterprise value of c.€680 million^1,2, with a further earn-out of up to €43 million¹ potentially payable in 2028 ...</p><p><a href=https://www.benzinga.com/pressreleases/26/04/g52073734/nexans-to-acquire-republic-wire-establishing-a-strategic-platform-in-the-united-states?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Nexans to acquire Republic Wire, establishing a strategic platform in the United States>Full story available on Benzinga.com</a></p> M&A News PARIS:NEX Press Releases Mon, 27 Apr 2026 17:46:14 +0000 Globe Newswire 52073734 at https://www.benzinga.com https://www.benzinga.com/m-a/26/04/52073002/shell-strikes-16-billion-mega-deal-to-conquer-canadas-energy-heartland?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>Shell PLC</strong> <a target="_blank" href="https://www.benzinga.com/quote/SHEL" rel="noreferrer noopener"><a href="https://www.benzinga.com/quote/SHEL" target="_blank" class="ticker-link" data-ticker="SHEL" data-exchange="NYSE" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/SHEL">SHEL</a>)</a></a> shares are trading lower Monday after the company said it agreed to acquire <strong>ARC Resources Ltd.</strong>, a Montney-focused producer in British Columbia and Alberta, in a cash-and-stock transaction.</p> <p>The deal carries an equity value of about $13.6 billion and an enterprise value of roughly $16.4 billion, including $2.8 billion in net debt and leases.</p> <p>Under the terms, ARC shareholders will receive 8.20 Canadian dollars in cash and 0.40247 Shell shares for each ARC share, implying a total value of 32.80 Canadian dollars per share. That represents a 20% premium to ARC&#8217;s 30-day volume-weighted average price.</p> <p>Shell said it will fund the purchase with $3.4 billion in cash and $10.2 billion in shares, issuing about 228 million shares. Both boards have unanimously approved the deal, which is expected to close in the second half of 2026, subject to regulatory and shareholder approvals.</p> <p>Shell reported <a target="_blank" href="https://www.benzinga.com/pressreleases/26/02/g50401478/shell-plc-4th-quarter-2025-and-full-year-unaudited-results" ...</p><p><a href=https://www.benzinga.com/m-a/26/04/52073002/shell-strikes-16-billion-mega-deal-to-conquer-canadas-energy-heartland?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Shell Strikes $16 Billion Mega-Deal To Conquer Canada&#039;s Energy Heartland>Full story available on Benzinga.com</a></p> ARX DFIV Equities Large Cap M&A News OCTA SHEL VGK why it's moving Top Stories Movers VGK US9220428745 ARX US0077671065 DFIV SHEL OCTA News M&A Equities Large Cap Top Stories Movers Benzinga Mon, 27 Apr 2026 17:24:22 +0000 Lekha Gupta 52073002 at https://www.benzinga.com https://www.benzinga.com/m-a/26/04/52072759/ligand-bets-on-royalty-growth-with-xoma-buyout-worth-over-700-million?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>Ligand Pharmaceuticals Inc. </strong><a href="https://www.benzinga.com/quote/LGND" target="_blank" class="ticker-link" data-ticker="LGND" data-exchange="NASDAQ" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/LGND">LGND</a>)</a> on Monday said it is <a target="_blank" href="https://www.benzinga.com/pressreleases/26/04/g52057111/ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligands-positi" rel="noreferrer noopener">expanding its royalty portfolio</a> through the acquisition of <strong>XOMA Royalty Corporation</strong> <a href="https://www.benzinga.com/quote/XOMA" target="_blank" class="ticker-link" data-ticker="XOMA" data-exchange="NASDAQ" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/XOMA">XOMA</a>)</a>.</p> <h2 class="wp-block-heading">Ligand Expands Portfolio With XOMA Royalty Acquisition</h2> <p>This move is expected to bolster Ligand&#8217;s long-term growth, adding new commercial products and enhancing its position as a <a target="_blank" href="https://www.benzinga.com/general/biotech" rel="noreferrer noopener">leading biopharma royalty aggregator</a>.</p> <p>Deal consideration includes $39.00 per share in cash, for a total equity value of approximately $739 million.</p> <p>XOMA Royalty stockholders are expected to separately receive one non-transferable Contingent Value Right per share entitling the holder to receive a portion of 75% of the net proceeds that may result from certain pending litigation at XOMA Royalty.&nbsp;</p> <h2 class="wp-block-heading">Updated Guidance Reflects Stronger Outlook</h2> <p>Ligand Pharmaceuticals announced its acquisition of XOMA Royalty, which is anticipated to be immediately accretive to adjusted earnings per ...</p><p><a href=https://www.benzinga.com/m-a/26/04/52072759/ligand-bets-on-royalty-growth-with-xoma-buyout-worth-over-700-million?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million>Full story available on Benzinga.com</a></p> benzai Biotech LGND M&A News XOMA Health Care Top Stories Movers Trading Ideas General LGND US53220K5048 XOMA BMG9825R2069 News M&A Biotech Health Care Top Stories Movers Trading Ideas General Benzinga Mon, 27 Apr 2026 17:18:03 +0000 Vandana Singh 52072759 at https://www.benzinga.com https://www.benzinga.com/pressreleases/26/04/g52070733/middle-states-commission-on-higher-education-advances-historic-merger-of-kean-university-and-new-j?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="left" style="padding-left:0px;">UNION, N.J., April 27, 2026 (GLOBE NEWSWIRE) -- The Middle States Commission on Higher Education (MSCHE) has advanced the merger between Kean University and New Jersey City University (NJCU), marking a historic milestone that will reshape public higher education in New Jersey. The merger will serve as a model for institutions nationwide pursuing partnerships that advance sustainability and expand student opportunities.  </p> <p align="left" style="padding-left:0px;">The merger will officially close on July 1, 2026, when Kean acquires control of NJCU. At that time, all NJCU employees will become new Kean employees. Following completion of the U.S. Department of Education&#39;s review in August 2026, the merger will be complete, the Jersey City campus will begin to formally operate as Kean Jersey City, and all NJCU students will become Kean students. </p> <p align="left" style="padding-left:0px;">"This is a defining moment for Kean University, and for the future of higher education in our state," said Lamont O. Repollet, Ed.D., president of Kean University. "With Middle States&#039; decision, we move forward with purpose and clarity, creating exceptional  opportunities for students across New Jersey and beyond. This merger strengthens Kean&#39;s ability to deliver an innovative, inclusive and high-quality education while expanding access for those who need it most." </p> <p align="left" style="padding-left:0px;">The decision from Middle States follows more than a year of intensive planning and collaboration between the two institutions and reflects a statewide effort to address NJCU&#039;s fiscal challenges and ensure long-term access to public higher education in Jersey City. In March 2025, the NJCU Board of Trustees voted to pursue a merger with Kean following direction from the state. The universities subsequently signed a letter of intent and, later, a definitive merger agreement, advancing a shared vision to launch Kean Jersey City and ensure long-term stability and success.  </p> <p align="left" style="padding-left:0px;">The merger process included the work of 15 advisory teams and broad engagement from faculty, staff and administrators at both institutions.  </p> <p align="left" style="padding-left:0px;">"The Board is deeply grateful to everyone who contributed to this effort over the past year," said Steve Fastook &#039;06H, chair of ...</p><p><a href=https://www.benzinga.com/pressreleases/26/04/g52070733/middle-states-commission-on-higher-education-advances-historic-merger-of-kean-university-and-new-j?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Middle States Commission on Higher Education Advances Historic Merger of Kean University and New Jersey City University>Full story available on Benzinga.com</a></p> M&A News Education Press Releases Mon, 27 Apr 2026 16:32:29 +0000 Globe Newswire 52070733 at https://www.benzinga.com https://www.benzinga.com/m-a/26/04/52061994/real-brokerage-to-acquire-re-max-in-880-million-deal?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>RE/MAX Holdings Inc.</strong> <a target="_blank" href="https://www.benzinga.com/quote/RMAX" rel="noreferrer noopener"><a href="https://www.benzinga.com/quote/RMAX" target="_blank" class="ticker-link" data-ticker="RMAX" data-exchange="NYSE" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/RMAX">RMAX</a>)</a></a> shares are up during Monday&#8217;s premarket session. <strong>The Real Brokerage, Inc.</strong> <a target="_blank" href="https://www.benzinga.com/quote/REAX" rel="noreferrer noopener"><a href="https://www.benzinga.com/quote/REAX" target="_blank" class="ticker-link" data-ticker="REAX" data-exchange="NASDAQ" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/REAX">REAX</a>)</a></a> disclosed that it will acquire RE/MAX for an <a target="_blank" href="https://www.benzinga.com/pressreleases/26/04/b52057151/real-to-acquire-remax-creating-a-leading-technology-enabled-global-real-estate-platform" rel="noreferrer noopener">enterprise value of around $880 million</a>.</p> <p>The acquisition will create a leading technology-enabled global real estate platform.</p> <h2 class="wp-block-heading">Deal Terms</h2> <p>The deal values each RE/MAX Holdings share at $13.80, based on Real&#8217;s closing price on April 24, 2026.</p> <p>Under the agreement, RE/MAX Holdings shareholders can choose either 5.152 shares of Real REMAX Group or $13.80 in cash. The cash payments are subject to proration, so the total cash consideration ranges from $60 million to $80 million.</p> <p>Real shareholders will receive one share of the combined Real REMAX Group for each existing share held.</p> <p>The companies expect the acquisition to close in the second half of 2026, subject to customary closing conditions and approvals.</p> <p>After closing, Real shareholders will own about 59% of the combined company, while RE/MAX Holdings shareholders will own roughly 41% on a fully diluted basis, assuming midpoint cash election.</p> <p>As of December 31, Real&#8217;s cash and cash equivalents <a target="_blank" ...</p><p><a href=https://www.benzinga.com/m-a/26/04/52061994/real-brokerage-to-acquire-re-max-in-880-million-deal?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Real Brokerage To Acquire RE/MAX In $880 Million Deal>Full story available on Benzinga.com</a></p> benzai Equities M&A News REAX RMAX why it's moving Small Cap Top Stories Movers RMAX REAX News M&A Equities Small Cap Top Stories Movers Benzinga Mon, 27 Apr 2026 13:38:59 +0000 Lekha Gupta 52061994 at https://www.benzinga.com https://www.benzinga.com/m-a/26/04/52061058/apollo-bets-big-on-car-interiors-snags-forvia-unit-in-strategic-buyout?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>Apollo Global Management, Inc. </strong><a target="_blank" href="https://www.benzinga.com/quote/APO" rel="noreferrer noopener"><a href="https://www.benzinga.com/quote/APO" target="_blank" class="ticker-link" data-ticker="APO" data-exchange="NYSE" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/APO">APO</a>)</a></a> shares rose in Monday&#8217;s premarket session after Apollo-managed funds <a target="_blank" href="https://www.benzinga.com/pressreleases/26/04/g52054086/apollo-funds-to-acquire-forvias-automotive-interiors-business" rel="noreferrer noopener">agreed to acquire</a> the Interiors Business Group of <strong>Forvia SE</strong> <a target="_blank" href="https://www.benzinga.com/quote/FURCF" rel="noreferrer noopener"><a href="https://www.benzinga.com/quote/FURCF" target="_blank" class="ticker-link" data-ticker="FURCF" data-exchange="OTC" rel="noopener">(OTC:<a class="ticker" href="https://www.benzinga.com/quote/FURCF">FURCF</a>)</a></a> in a carve-out transaction. The companies did not disclose the terms of the deal.</p> <h2 class="wp-block-heading">Deal Overview</h2> <p>The Interiors Business is a global supplier of automotive interior systems, including instrument panels, door panels, and center consoles, serving major OEMs.</p> <p>The company operates manufacturing and engineering facilities across Europe, North America, and Asia and supports large-scale vehicle programs.</p> <h2 class="wp-block-heading">Strategy and Positioning</h2> <p>Apollo said the standalone business will be positioned to capitalize on demand for advanced cabin design, premium materials, and new technologies.</p> <p>It plans to support its transition into an independent company with dedicated leadership and resources.</p> <h2 class="wp-block-heading">Timeline and Commentary</h2> <p>The transaction is subject to regulatory approvals and employee consultations and is expected to close in ...</p><p><a href=https://www.benzinga.com/m-a/26/04/52061058/apollo-bets-big-on-car-interiors-snags-forvia-unit-in-strategic-buyout?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Apollo Bets Big On Car Interiors, Snags Forvia Unit In Strategic Buyout>Full story available on Benzinga.com</a></p> APO benzai CWB Equities FURCF GPZ M&A News RSPF why it's moving Top Stories Movers APO US0376123065 CWB US78464A3591 FURCF RSPF GPZ News M&A Equities Top Stories Movers Benzinga Mon, 27 Apr 2026 13:16:46 +0000 Akanksha Bakshi 52061058 at https://www.benzinga.com https://www.benzinga.com/markets/small-cap/26/04/52059966/whats-going-on-with-oio-group-stock-monday?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>OIO Group</strong> <a target="_blank" href="https://www.benzinga.com/quote/OIO" rel="noreferrer noopener"><a href="https://www.benzinga.com/quote/OIO" target="_blank" class="ticker-link" data-ticker="OIO" data-exchange="NASDAQ" rel="noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/OIO">OIO</a>)</a></a> shares are trading higher during Monday&#8217;s premarket session after sinking 58.44% to close sharply lower on Friday.</p> <p>Last week, the company completed a <a target="_blank" href="https://www.benzinga.com/pressreleases/26/04/g52018115/oio-group-completes-de-tomaso-business-combination-establishing-new-control-and-strategic-platform" rel="noreferrer noopener">business combination with</a> <strong>De Tomaso Automobili Holdings Limited</strong>, marking a significant shift in control.</p> <h2 class="wp-block-heading">Completes De Tomaso Deal</h2> <p>The completion of the business combination with De Tomaso was announced on April 23, 2026. The company positioned <strong>Norman Choi</strong>, De Tomaso&#8217;s founder, as the controlling shareholder of OIO Group.</p> <p>He will ...</p><p><a href=https://www.benzinga.com/markets/small-cap/26/04/52059966/whats-going-on-with-oio-group-stock-monday?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=What&#039;s Going On With OIO Group Stock Monday?>Full story available on Benzinga.com</a></p> benzai Equities M&A News OIO Small Cap Top Stories Movers OIO News M&A Equities Small Cap Top Stories Movers Benzinga Mon, 27 Apr 2026 12:40:49 +0000 Lekha Gupta 52059966 at https://www.benzinga.com https://www.benzinga.com/pressreleases/26/04/g52059587/critical-metals-to-acquire-european-lithium?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/CRML" rel="nofollow">CRML</a>) ("Critical Metals Corp." or the "Company"), a leading critical mineral mining company, today announced the signing of a letter of intent whereby Critical Metals has proposed to acquire all of the outstanding shares of European Lithium Ltd. (ASX: EUR) ("European Lithium") (the "Proposed Transaction"). Under the Proposed Transaction, European Lithium shareholders will receive 0.035 shares of Critical Metals for each European Lithium share held (the "Exchange Ratio"). Based on the Exchange Ratio and considering the unaffected closing price of Critical Metals and the US Dollar to Australian Dollar exchange rate on April 22, 2026 (the &#34;Measurement Date&#34;), the total aggregate consideration payable to European Lithium equity holders is approximately US$835 million.</p> <p align="justify">The Proposed Transaction is subject to the signing of a definitive agreement.</p> <p align="justify"><strong>Strong Rationale for the Proposed Transaction</strong></p> <p align="justify">The Proposed Transaction is a logical combination that has a compelling strategic rationale and is expected to create value for Critical Metals shareholders.</p> <p align="justify">Minimize Critical Metals Dilution and Increase Critical Metals Public Float: European Lithium owns 45,536,338 shares of Critical Metals (the "Cross-holding Shares"), representing approximately 34% of Critical Metals outstanding shares as of the Measurement Date. As of the Measurement Date, the Cross-holding Shares had a market value of US$540 million without considering any potential control block value premium. Upon completion of the Proposed Transaction, Critical Metals intends to cancel the Cross-holding Shares which will substantially reduce the associated Critical Metals shareholder dilution resulting from the Proposed Transaction yet materially increase Critical Metals&#039; public float which is expected to augment Critical Metals&#039; already strong trading liquidity profile.</p> <p align="justify">Consolidation of Tanbreez Ownership: European Lithium owns 7.5% of the Tanbreez Rare Earth Project in Greenland ("Tanbreez") and following completion of the Proposed Transaction, Critical Metals is positioned to consolidate 100% of Tanbreez, which will simplify the ownership, decision making and financing strategy for Tanbreez as it is advanced towards a development decision.</p> <p align="justify">Fortification of Critical Metals&#39; Balance Sheet: European Lithium has a cash balance of approximately AUD$306 million (approximately US$219 million) as of March 31, 2026, and Critical Metals, which currently has a standalone cash balance of approximately US$124 million, will have a robust balance sheet to accelerate the development of Tanbreez into a strong rare earth market that requires new sources of heavy rare earth elements from Western allied nations. In addition, excluding the Cross-holding Shares, European Lithium currently holds marketable securities with a market value of approximately US$11 million.</p> <p align="justify"><strong>Transaction Benefits for Critical Metals Shareholders</strong></p> <ul type="disc"> <li style="margin-bottom:8pt; text-align:justify;">Improved Capital Markets and Optimal Pro Forma Ownership<br /> <ul type="circle"> <li style="margin-bottom:8pt; text-align:justify;">Removes overhang from regular block trade dispositions of Critical Metals shares by European Lithium at significant discounts to the prevailing market price</li> <li style="margin-bottom:8pt; text-align:justify;">Critical Metals&#039; expected cancellation of the Cross-holding Shares substantially reduces the associated shareholder dilution resulting from the Proposed Transaction, yet materially increases Critical Metals&#039; public float, which is expected to augment Critical Metals&#039; already strong trading liquidity profile</li> </ul> </li> <li style="margin-bottom:8pt; text-align:justify;">Removal of Large Shareholder<br /> <ul type="circle"> <li style="margin-bottom:8pt; text-align:justify;">Removes a shareholder with 34% ownership from the shareholder register and puts control of Critical Metals in the market, which may make Critical Metals more attractive to future potential strategic investors and/or future potential acquirers</li> </ul> </li> <li style="margin-bottom:8pt; text-align:justify;">100% Ownership of Tanbreez<br /> <ul type="circle"> <li style="margin-bottom:8pt; text-align:justify;">Positioned to consolidate ...</li></ul></li></ul><p><a href=https://www.benzinga.com/pressreleases/26/04/g52059587/critical-metals-to-acquire-european-lithium?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Critical Metals to Acquire European Lithium>Full story available on Benzinga.com</a></p> CRML M&A News Press Releases Mon, 27 Apr 2026 12:30:00 +0000 Globe Newswire 52059587 at https://www.benzinga.com https://www.benzinga.com/pressreleases/26/04/g52058557/shell-announces-agreement-to-acquire-canadian-energy-company-arc-resources-ltd-arc?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p><b>Shell announces agreement to acquire Canadian energy company, ARC Resources Ltd ("ARC").</b></p> <ul> <li style="margin-top:0cm; margin-bottom:0cm;">Acquisition accelerates Shell&#039;s strategy by adding 370 kboe/d¹ immediately across liquids and gas leading to a 4% production CAGR² through to 2030, compared to 2025.</li> <li style="margin-top:0cm; margin-bottom:0cm;">Increases Shell&#039;s exposure to long-duration, low-cost and top quartile low carbon intensity shale gas and liquids production in Canada&#039;s Montney basin, delivering value for decades.</li> <li style="margin-top:0cm; margin-bottom:0cm;">Transaction expected to generate double digit returns, bolstering long-term cashflows, and is accretive to free cash flow per share from 2027 onwards.</li> </ul> <p>London, United Kingdom; Calgary, Canada; April 27, 2026</p> <p>Shell plc (LSE, NYSE:<a class="ticker" href="https://www.benzinga.com/quote/SHEL" rel="nofollow">SHEL</a>, Euronext: Shell) has entered into a definitive agreement to acquire ARC Resources Ltd. (TSX:<a class="ticker" href="https://www.benzinga.com/quote/ARX" rel="nofollow">ARX</a>), an energy company focused on the Montney shale basin in British Columbia and Alberta, Canada.</p> <p>"ARC is a high-quality, low-cost and top quartile low carbon intensity producer operating in the Montney shale basin that complements our existing footprint in Canada and strengthens our resource base for decades to come. We are accessing uniquely positioned assets and welcoming colleagues that bring deep expertise which, combined with Shell&#039;s strong basin level performance, provides a compelling proposition for shareholders." said <b>Shell&#039;s chief executive officer, Wael Sawan</b>. "This establishes Canada as a heartland for Shell while furthering our strategy to deliver more value with less emissions."</p> <p>"This combination is a great opportunity for ARC to realise value for our shareholders and continue to benefit from Shell&#039;s success in the future. ARC is combining with a company that has a global portfolio of best-in-class assets," said <b>ARC president and CEO, Terry Anderson</b>. "I&#039;m excited that ARC&#039;s assets and world class people will play an important role in helping Shell to further strengthen Canada&#039;s resource landscape whilst also providing the secure energy that the world needs."</p> <p>This acquisition increases Shell&#039;s production CAGR from 1% as outlined at our 2025 Capital Market&#039;s Day to 4%³, compared to 2025, and supports Shell&#039;s aim to sustain material liquids production of ~1.4 million barrels per day towards 2030 and beyond. The transaction combines ARC&#039;s more than 1.5 million net acres with Shell&#039;s ~440 thousand net acres in the Montney formation and adds ~2 billion barrels of oil equivalent proved plus probable reserves at the end of 2025⁴. Last year, ~40 per cent of ARC&#039;s production was liquids, which accounted for ~70 per cent of its revenues. In addition, ARC&#039;s proved plus probable gas reserves have the potential to support Shell&#039;s growth in LNG in Canada.</p> <p>Under the terms of the agreement, ARC&#039;s shareholders will receive CAD 8.20 in cash and 0.40247 ordinary shares of Shell for each ARC share, representing approximately 25% cash and 75% shares as of the 24th April 2026 market closing. Based on Shell&#039;s closing share price on this date of GBP 33.08 and GBP:CAD exchange ratio of 1.8480, this translates to a consideration of CAD 32.80 per share, which represents a 20 per cent premium to ARC&#039;s 30-day⁵ VWAP. This equates to an equity value of approximately US$13.6 billion. Shell will take on approximately US$2.8 billion in net debt and leases resulting in an enterprise value of approximately US$16.4 billion. The equity value of US$13.6 billion will be funded via US$3.4 billion in cash and US$10.2 billion in Shell shares, the latter valued based on Shell&#039;s closing price on the 24th April and the issuance of approximately 228 million ordinary shares.</p> <p>The boards of both companies have unanimously supported the transaction, which is expected to close in the second half of 2026, subject to ARC shareholder, court and regulatory approvals.</p> <p><b>Notes to Editors</b></p> <ul> <li style="margin-top:0cm; margin-bottom:0cm;">Last year, ARC reported production of 374 thousand barrels of oil equivalent per day (before royalty burdens). Its operations are situated in the same region as Shell&#039;s existing Groundbirch asset in British Columbia and Gold Creek project in neighbouring Alberta.</li> <li style="margin-top:0cm; margin-bottom:0cm;">Shell&#039;s Groundbirch assets supply gas to the LNG Canada liquefaction plant (Shell share 40 per cent) and the domestic gas market. ARC&#039;s business will therefore also be reported as part of Shell&#039;s leading Integrated Gas division.</li> <li style="margin-top:0cm; margin-bottom:0cm;">The agreement grows Shell&#039;s producing interests in Canada and complements Shell&#039;s existing LNG footprint and extensive downstream businesses including refining, chemicals, fuel retail, aviation, lubricants and low-carbon solutions.</li> <li style="margin-top:0cm; margin-bottom:0cm;">Shell&#039;s 2030 ...</li></ul><p><a href=https://www.benzinga.com/pressreleases/26/04/g52058557/shell-announces-agreement-to-acquire-canadian-energy-company-arc-resources-ltd-arc?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Shell announces agreement to acquire Canadian energy company, ARC Resources Ltd (&quot;ARC&quot;).>Full story available on Benzinga.com</a></p> M&A News SHEL TSX:ARX Press Releases Mon, 27 Apr 2026 12:00:00 +0000 Globe Newswire 52058557 at https://www.benzinga.com https://www.benzinga.com/pressreleases/26/04/g52058177/oceanfirst-financial-corp-and-flushing-financial-corporation-announce-receipt-of-all-requisite-reg?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="justify">RED BANK, N.J. and UNIONDALE, N.Y., April 27, 2026 (GLOBE NEWSWIRE) -- <strong>OceanFirst Financial Corp. (NASDAQ: "OCFC") ("OceanFirst"), </strong>the holding company for OceanFirst Bank N.A., and Flushing Financial Corporation (NASDAQ: "FFIC") ("Flushing"), the holding company for Flushing Bank, today jointly announced the receipt of regulatory approval from the Board of Governors of the Federal Reserve System (the "Federal Reserve") on April 24, 2026, to complete the proposed merger of Flushing with and into OceanFirst. The Federal Reserve approval follows recent approvals from the New York State Department of Financial Services and the Office of the Comptroller of the Currency on March 23, 2026, and April 6, 2026, respectively. All necessary regulatory approvals to complete the proposed transaction have now been received. In addition, as previously announced, both OceanFirst and Flushing received shareholder approval for the transaction on April 2, 2026.</p> <p align="justify">OceanFirst and Flushing expect to close the merger no later than June 1, 2026, subject to the satisfaction or waiver of the remaining customary closing conditions.</p> <p align="justify">OceanFirst also announced that its 2026 Annual Meeting of Stockholders (the "Annual Meeting") will be held virtually on Wednesday May 27, 2026 at 8:00 a.m. Eastern Time. The record date for stockholders to vote at the Annual Meeting is Thursday, April 2, 2026. Voting before the meeting is encouraged, even for stockholders planning to participate in the virtual webcast. Votes may be submitted by telephone or online according to the instructions on the proxy card or by mail. A link to the live webcast is available by visiting oceanfirst.com - Investor Relations. Access will begin at 7:45 a.m. Eastern Time to allow time for stockholders to log-in with the control number provided on the proxy card prior to 8:00 a.m. Eastern Time scheduled start. Eligible stockholders may also vote during the live meeting online at <a href="http://www.virtualshareholdermeeting.com/OCFC2026" title="www.virtualshareholdermeeting.com/OCFC2026" rel="nofollow">www.virtualshareholdermeeting.com/OCFC2026</a> by entering the 16-digit control number included on the proxy card or notice. As a reminder, participants of the meeting are not required to vote. Additional information regarding virtual access to the meeting will be distributed prior to the meeting.</p> <p align="justify"><strong><u>About OceanFirst</u></strong></p> <p align="justify">OceanFirst Financial Corp.&#039;s subsidiary, OceanFirst Bank N.A., founded in 1902, is a $14.6 billion regional bank serving business and retail customers throughout New Jersey and the major metropolitan areas from Massachusetts through Virginia. OceanFirst Bank delivers commercial and residential financing, treasury management, trust and asset management, and deposit services and is one of the largest and oldest community-based financial institutions headquartered in New Jersey. To learn more about OceanFirst, please visit us at <a href="https://www.globenewswire.com/Tracker?data=pQ7XH0yWylzL0kJi62BgPfCQmgfkD-IQ3f7MMWFJzXQ5P_OLaWRpflraA5hL1nz0_EUJ9XY39sDuJ4dx2jA3lTn4qNeufhjtyxDsGl7QrOs=" rel="nofollow" target="_blank" rel="nofollow">www.oceanfirst.com</a>.</p> <p align="justify"><strong><u>About Flushing</u></strong></p> <p align="justify">Flushing Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/FFIC" rel="nofollow">FFIC</a>) is the holding company for Flushing Bank, an FDIC insured, New York State-chartered commercial bank that operates banking offices in Queens, Brooklyn, Manhattan, and on Long Island. The Bank has been building relationships with families, business owners, and communities since 1929. Today, it offers the products, services, and conveniences associated with large commercial banks, including a full complement of deposit, loan, equipment finance, and cash management services. Rewarding customers with personalized attention and bankers that can communicate in the languages prevalent within these multicultural markets is what makes the Bank uniquely different. As an Equal Housing Lender and leader in real estate lending, the Bank&#39;s experienced lending teams create mortgage solutions for real estate owners and property managers both within and outside the New York City metropolitan area. The Bank also fosters relationships with consumers nationwide through its online banking division with the iGObanking and BankPurely brands.</p> <p align="justify">Additional information on Flushing Bank and Flushing Financial Corporation may be obtained by visiting the Company&#39;s website at FlushingBank.com.</p> <p><strong><u>Cautionary Statements Regarding Forward-Looking Information </u></strong></p> <p align="justify">This press release contains certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between OceanFirst and Flushing and the proposed investment by affiliates of funds managed by Warburg Pincus LLC ("Warburg") in equity securities of OceanFirst. Forward-looking statements may be identified by the use of the words such as " estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek," "strategy," "future," "opportunity," "may," "could," "target," "should," "will," "would," "will be," "will continue," "will likely result," or similar expressions that predict or indicate future events or trends or that are not statements of historical matters, although not all forward-looking statements contain such identifying words. These ...</p><p><a href=https://www.benzinga.com/pressreleases/26/04/g52058177/oceanfirst-financial-corp-and-flushing-financial-corporation-announce-receipt-of-all-requisite-reg?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=OceanFirst Financial Corp. and Flushing Financial Corporation Announce Receipt of All Requisite Regulatory and Shareholder Approvals to Complete Proposed Merger and Annual Meeting Date>Full story available on Benzinga.com</a></p> Annual Meetings & Shareholder Rights FFIC M&A News OCFC Press Releases Mon, 27 Apr 2026 11:45:00 +0000 Globe Newswire 52058177 at https://www.benzinga.com https://www.benzinga.com/pressreleases/26/04/g52057111/ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligands-positi?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="center"><em>Transaction expands Ligand&#039;s royalty portfolio to more than 200 assets and adds seven new commercial products</em></p> <p align="center"><em>Bolsters and diversifies Ligand&#039;s long-term compounding growth, adding a complementary portfolio across development stages, therapeutic areas, and modalities to broaden patient access and improve lives</em></p> <p align="center"><em>Acquisition is expected to be immediately accretive to Ligand adjusted EPS; Ligand increases 2026 adjusted EPS guidance to $8.50-$9.50</em>^<em>1</em><em> and expects the transaction to be accretive by $1.50 per share to adjusted EPS in 2027</em>^<em>2</em></p> <p align="center"><em>Ligand to hold investor call at 8:00 a.m. ET today</em></p> <p align="justify">JUPITER, Fla. and EMERYVILLE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/LGND" rel="nofollow">LGND</a>) and XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/XOMA" rel="nofollow">XOMA</a>), both biotechnology royalty aggregators, today announced that the companies have entered into a definitive agreement under which Ligand will acquire XOMA Royalty for $39.00 per share of common stock in cash, for a total equity value of approximately $739 million. XOMA Royalty stockholders are expected to separately receive one non-transferable Contingent Value Right ("CVR") per share entitling the holder to receive a portion of 75% of the net proceeds that may result from certain pending litigation at XOMA Royalty. The cash purchase price at close represents an approximately 14% premium to XOMA Royalty&#039;s 30 trading day volume weighted average price as of April 24, 2026, the last trading day prior to announcement of the transaction. </p> <p align="justify">&#34;The acquisition of XOMA Royalty presents a compelling opportunity for us to strengthen and diversify our portfolio across all stages of clinical development and accelerate our long-term profitable growth. This acquisition will add seven marketed products and nearly double our portfolio of Phase 2 and 3 assets, which we believe will create significant value for our stockholders, all through a single transaction," said Todd Davis, CEO of Ligand. "The XOMA Royalty team has built a robust portfolio of complementary biopharmaceutical assets, and this acquisition will enable us to further grow and diversify in areas such as ophthalmology, oncology, CNS and rare diseases. With XOMA Royalty, we believe we will now be in an even stronger position to leverage our expertise and capital base to support broader patient access and advance late-stage clinical programs in a way that enhances patient outcomes and improves lives.</p> <p align="justify">With this agreement, Ligand adds over 120 commercial, clinical, and preclinical stage assets to its broad and growing royalty portfolio highlighted by Roche&#039;s VABYSMO&#xAE; (faricimab-svoa), Day One Pharmaceuticals&#039; OJEMDA&#x2122; (tovorafenib), Zevra Therapeutics&#039; MIPLYFFA&#x2122; (arimoclomol), and 14 programs in late-stage development, highlighted by Takeda&#039;s mezagitamab and certain assets from Takeda&#039;s externalized asset portfolio, including osavampator, volixibat and OHB-607. The addition of the XOMA Royalty portfolio is expected to increase Ligand&#039;s long-term growth profile.</p> <p align="justify">"After evaluating a broad range of strategic and financing alternatives, we believe combining our diverse portfolio with a company that shares our commitment to helping the biopharmaceutical industry thrive represents the most compelling outcome for XOMA Royalty&#039;s stockholders," said Owen Hughes, CEO of XOMA Royalty. "The structure delivers to our stockholders both the intrinsic value of XOMA&#039;s portfolio today and the optionality associated with our ongoing litigation with Janssen Biotech (now Johnson &amp; Johnson Innovative Medicine) via the CVR. Since 2023, we significantly scaled our portfolio with the addition of multiple assets and two platform technologies, enabling numerous upcoming regulatory and clinical catalysts beginning in 2026 and continuing over the next several years. We believe coupling Ligand&#039;s business development capabilities, portfolio management expertise plus the inherent financial synergies from this transaction position the combined company to maximize long-term value across the combined portfolio."</p> <p align="justify"><strong>Transaction Terms </strong><br />Under the terms of the merger agreement, Ligand will acquire all the outstanding shares of common stock of XOMA Royalty for $39.00 per share in cash. The cash consideration for the transaction is expected to be funded with Ligand&#039;s existing cash on hand and borrowings under Ligand&#039;s existing credit facility. XOMA Royalty&#039;s Series X Convertible Preferred Stock is expected to be converted into shares of common stock at its stated fixed price prior to closing, whereas the outstanding shares of Series A Preferred Stock and Series B Preferred Stock are expected to be redeemed. XOMA Royalty stockholders also will receive one CVR per share. The CVRs are intended to provide XOMA Royalty stockholders with the opportunity to receive certain net proceeds, if any are recovered, from certain ongoing litigation with regard to XOMA Royalty&#039;s dispute with Janssen Biotech regarding the commercialization of TREMFYA&#xAE;.</p> <p align="justify"><strong>Timing and Approvals </strong><br />The transaction has been unanimously approved by the Ligand and XOMA Royalty Boards of Directors. Entities affiliated with BVF Partners, which own approximately 21% of the outstanding shares of XOMA Royalty common stock and approximately 44% assuming the conversion of their Series X Convertible Preferred Stock, have agreed to convert such shares into shares of XOMA Royalty common stock prior to closing and have entered into a voting agreement in support of the transaction. In addition, XOMA Royalty&#039;s directors and officers have also entered into voting agreements in support of the transaction. The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions, approval by XOMA Royalty stockholders and the receipt of certain regulatory approvals.</p> <p align="justify"><strong>Financial Guidance Update</strong><br />The transaction is expected to close in the third quarter ...</p><p><a href=https://www.benzinga.com/pressreleases/26/04/g52057111/ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthening-ligands-positi?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand&#039;s Position as a Leading Biopharma Royalty Aggregator>Full story available on Benzinga.com</a></p> LGND M&A News XOMA Press Releases Mon, 27 Apr 2026 11:00:00 +0000 Globe Newswire 52057111 at https://www.benzinga.com https://www.benzinga.com/m-a/26/04/52055822/why-is-organon-stock-skyrocketing-monday?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel <p><strong>Organon &amp; Co. </strong><a target="_blank" href="https://www.benzinga.com/quote/OGN" rel="noreferrer noopener"><a href="https://www.benzinga.com/quote/OGN" target="_blank" class="ticker-link" data-ticker="OGN" data-exchange="NYSE" rel="noopener">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/OGN">OGN</a>)</a></a> shares rose Monday after <strong>Sun Pharmaceutical Industries Limited&nbsp;</strong><a target="_blank" href="https://www.benzinga.com/pressreleases/26/02/b50572130/organon-reports-results-for-the-fourth-quarter-and-full-year-ended-december-31-2025" rel="noreferrer noopener">agreed to acquire</a> the company.</p> <p>The all-cash deal offers $14.00 per share and values Organon at an enterprise value of $11.75 billion.</p> <p>The boards approved the deal, under which Sun Pharma will acquire 100% of Organon through a merger with a subsidiary.</p> <p>The companies expect to close the transaction in early 2027, subject to regulatory and shareholder approvals. Sun Pharma will fund the deal through a combination of cash and bank financing.</p> <h2 class="wp-block-heading">Financials and Business Overview</h2> <p>Organon operates in over 140 countries and offers more than 70 products. Its portfolio spans Women&#8217;s Health, General Medicines, and biosimilars.</p> <p>For the year ended December 31, 2025, the company <a target="_blank" href="https://www.benzinga.com/pressreleases/26/02/b50572130/organon-reports-results-for-the-fourth-quarter-and-full-year-ended-december-31-2025" rel="noreferrer noopener">reported</a> revenue of $6.2 billion and adjusted EBITDA of $1.9 billion.</p> <p>It had $8.6 billion in debt and $574 million in cash.</p> <h2 class="wp-block-heading">Strategic Rationale and Outlook</h2> <p>The acquisition supports Sun Pharma&#8217;s strategy to expand its Innovative Medicines business and strengthen its Established Brands and Branded Generics portfolio.</p> <p>It also enables entry into biosimilars as a top-10 global player.</p> <p>The ...</p><p><a href=https://www.benzinga.com/m-a/26/04/52055822/why-is-organon-stock-skyrocketing-monday?utm_source=benzinga_taxonomy&amp;utm_medium=rss_feed_free&amp;utm_content=taxonomy_rss&amp;utm_campaign=channel alt=Why Is Organon Stock Skyrocketing Monday?>Full story available on Benzinga.com</a></p> benzai Equities M&A News OGN SLYV why it's moving XPH Health Care Top Stories Movers XPH US78464A7220 SLYV OGN News M&A Equities Health Care Top Stories Movers Benzinga Mon, 27 Apr 2026 09:57:38 +0000 Akanksha Bakshi 52055822 at https://www.benzinga.com